Literature DB >> 17289448

The determination of organophosphonate nerve agent metabolites in human urine by hydrophilic interaction liquid chromatography tandem mass spectrometry.

Douglas B Mawhinney1, Elizabeth I Hamelin, Rheaclare Fraser, Sathya S Silva, Antonis J Pavlopoulos, Robert J Kobelski.   

Abstract

A sensitive, robust isotope dilution LC/MS/MS method is presented for the quantitative analysis of human urine for the alkyl methylphosphonic acid metabolites of five organophosphorus nerve agents (VX, rVX or VR, GB or Sarin, GD or Soman, and GF or Cyclosarin). The selective sample preparation method employs non-bonded silica solid-phase extraction and is partially automated. While working with a mobile phase composition that enhances the electrospray ionization process, the hydrophilic interaction chromatography method results in a 5-min injection-to-injection cycle time, excellent peak shapes and adequate retention (k'=3.1). These factors lead to limits of detection for these metabolites as low as 30 pg/mL in a 1-mL sample of human urine. The quality control data (15 and 75 ng/mL) demonstrate accurate (-0.5 to +3.4%) and precise (coefficients of variation of 2.1-3.6%) quantitative results over the clinically relevant urine concentration range of 1-200 ng/mL for a validation set of 20 standard and quality control sets prepared by five analysts over 54 days. The selectivity of the method is demonstrated for a 100-individual reference range study, as well as the analysis of relevant biological samples. The combined sample preparation and analysis portions of this method have a throughput of 288 samples per day.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289448     DOI: 10.1016/j.jchromb.2007.01.023

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  11 in total

1.  Enhancing the response of alkyl methylphosphonic acids in negative electrospray ionization liquid chromatography tandem mass spectrometry by post-column addition of organic solvents.

Authors:  Douglas B Mawhinney; Rayman D Stanelle; Elizabeth I Hamelin; Robert J Kobelski
Journal:  J Am Soc Mass Spectrom       Date:  2007-07-29       Impact factor: 3.109

2.  Quantitation of five organophosphorus nerve agent metabolites in serum using hydrophilic interaction liquid chromatography and tandem mass spectrometry.

Authors:  Elizabeth I Hamelin; Nicholas D Schulze; Rebecca L Shaner; Rebecca M Coleman; Richard J Lawrence; Brian S Crow; E M Jakubowski; Rudolph C Johnson
Journal:  Anal Bioanal Chem       Date:  2014-03-15       Impact factor: 4.142

3.  Evaluation of Multiple Blood Matrices for Assessment of Human Exposure to Nerve Agents.

Authors:  Nicholas D Schulze; Elizabeth I Hamelin; W Rucks Winkeljohn; Rebecca L Shaner; Brian J Basden; B Rey deCastro; Brooke G Pantazides; Jerry D Thomas; Rudolph C Johnson
Journal:  J Anal Toxicol       Date:  2016-02-08       Impact factor: 3.367

4.  Comparison of high-resolution and tandem mass spectrometry for the analysis of nerve agent metabolites in urine.

Authors:  Elizabeth I Hamelin; William Bragg; Rebecca L Shaner; Leigh L Swaim; Rudolph C Johnson
Journal:  Rapid Commun Mass Spectrom       Date:  2013-08-15       Impact factor: 2.419

5.  Investigation of dried blood sampling with liquid chromatography tandem mass spectrometry to confirm human exposure to nerve agents.

Authors:  Rebecca L Shaner; Rebecca M Coleman; Nicholas Schulze; Kelsey Platanitis; Ashli A Brown; Craig Seymour; Pearl Kaplan; Jonas Perez; Elizabeth I Hamelin; Rudolph C Johnson
Journal:  Anal Chim Acta       Date:  2018-06-20       Impact factor: 6.558

6.  High-Confidence Qualitative Identification of Organophosphorus Nerve Agent Adducts to Human Butyrylcholinesterase.

Authors:  Thomas P Mathews; Melissa D Carter; Darryl Johnson; Samantha L Isenberg; Leigh Ann Graham; Jerry D Thomas; Rudolph C Johnson
Journal:  Anal Chem       Date:  2017-01-24       Impact factor: 6.986

7.  A high-throughput UHPLC-MS/MS method for the quantification of five aged butyrylcholinesterase biomarkers from human exposure to organophosphorus nerve agents.

Authors:  Leigh Ann Graham; Darryl Johnson; Melissa D Carter; Emily G Stout; Huseyin A Erol; Samantha L Isenberg; Thomas P Mathews; Jerry D Thomas; Rudolph C Johnson
Journal:  Biomed Chromatogr       Date:  2016-10-09       Impact factor: 1.902

8.  Simultaneous measurement of tabun, sarin, soman, cyclosarin, VR, VX, and VM adducts to tyrosine in blood products by isotope dilution UHPLC-MS/MS.

Authors:  Brian S Crow; Brooke G Pantazides; Jennifer Quiñones-González; Joshua W Garton; Melissa D Carter; Jonas W Perez; Caroline M Watson; Dennis J Tomcik; Michael D Crenshaw; Bobby N Brewer; James R Riches; Sarah J Stubbs; Robert W Read; Ronald A Evans; Jerry D Thomas; Thomas A Blake; Rudolph C Johnson
Journal:  Anal Chem       Date:  2014-10-06       Impact factor: 6.986

9.  Protein tyrosine adduct in humans self-poisoned by chlorpyrifos.

Authors:  Bin Li; Peter Eyer; Michael Eddleston; Wei Jiang; Lawrence M Schopfer; Oksana Lockridge
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-06       Impact factor: 4.219

10.  Recent advances in the treatment of organophosphorous poisonings.

Authors:  Mahdi Balali-Mood; Hamidreza Saber
Journal:  Iran J Med Sci       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.